Detection of TMPRSS2-ERG Fusion Gene Expression in Prostate Cancer Specimens by a Novel Assay Using Branched DNA

Urology

Volumn 74, Issue 5, 2009, Pages 1156-1161

  Lu, Bin ^a   Maqsodi, Botoul ^b   Yang, Wen ^b   McMaster, Gary K ^b   Perner, Sven ^c,d   Regan, Meredith ^e   Bubley, Glenn J ^f   Balk, Steven P ^f   Rubin, Mark ^c   Sanda, Martin G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Thermo Fisher Scientific   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTEIN TMPRSS 2 ERG; UNCLASSIFIED DRUG;

ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CONTROLLED STUDY; DNA DETERMINATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; ONCOGENE FUSION; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS;

EID: 70350443351     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.087     Document Type: Article

References (22)

1. Tomlins S.A., Rhodes D.R., Perner S., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
2. Tomlins S.A., Mehra R., Rhodes D.R., et al. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66 (2006) 3396-3400
3. Perner S., Demichelis F., Beroukhim R., et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66 (2006) 8337-8341
4. Soller M.J., Isaksson M., Elfving P., et al. Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer. Genes Chromosomes Cancer 45 (2006) 717-719
5. Wang J., Cai Y., Ren C., et al. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 66 (2006) 8347-8351
6. Yoshimoto M., Joshua A.M., Chilton-Macneill S., et al. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 8 (2006) 465-469
7. Petrovics G., Liu A., Shaheduzzaman S., et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome. Oncogene 24 (2005) 3847-3852
8. Laxman B., Tomlins S.A., Mehra R., et al. Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia 8 (2006) 885-888
9. Reynolds A., Leake D., Boese Q., et al. Rational siRNA design for RNA interference. Nat Biotechnol 22 (2004) 326-330
10. Soutschek J., Akinc A., Bramlage B., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432 (2004) 173-178
11. Yang W., Maqsodi B., Ma Y., et al. Direct quantification of gene expression in homogenates of formalin-fixed, paraffin-embedded tissues. Biotechniques 40 (2006) 481-486
12. Mosquera J.M., Perner S., Demichelis F., et al. Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol 212 (2007) 91-101
13. Saramaki O., and Visakorpi T. Chromosomal aberrations in prostate cancer. Front Biosci 12 (2007) 3287-3301
14. Perner S., Schmidt F.H., Hofer M.D., et al. [TMPRSS2-ETS gene fusion in prostate cancer]. Urologe A 46 (2007) 754-760
15. Hessels D., Smit F.P., Verhaegh G.W., et al. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res 13 (2007) 5103-5108
16. Perner S., Mosquera J.M., Demichelis F., et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 31 (2007) 882-888
17. Camparo P., and Vieillefond A. [Molecular aspects of prostate cancer: recent data from the literature]. Bull Cancer 94 suppl 7 (2007) F77-F88
18. Cerveira N., Ribeiro F.R., Peixoto A., et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 8 (2006) 826-832
19. Nam R.K., Sugar L., Wang Z., et al. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 6 (2007) 40-45
20. Demichelis F., Fall K., Perner S., et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 26 (2007) 4596-4599
21. Mosquera J.M., Perner S., Genega E.M., et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 14 (2008) 3380-3385
22. Hermans K.G., van Marion R., van Dekken H., et al. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res 66 (2006) 10658-10663